| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 02/05/2004 | US20040023933 Use for the treatment of diseases having an inflammatory basis of compounds or salts thereof, having the following general formula (I): A-Xt-L-(W)p-NO2 wherein A contains the radical of a drug, Xt and W arc bivalent radicals, L, is a |
| 02/05/2004 | US20040023923 Beta -Glucan which is cold-water soluble and is capable of forming a gel. The solubility is greater than 2% by weight in water at a temperature below approximately 50 degrees C. A process for preparing the beta -glucan by recovering the |
| 02/05/2004 | US20040023883 IGF-I and insulin variants are provided that selectively bind to IGFBP-1 or IGFBP-3. These agonist variants are useful, for example, to improve the half-lives of IGF-I and insulin, respectively. |
| 02/05/2004 | US20040023869 Interleukin-1 inhibitors in the treatment of diseases |
| 02/05/2004 | US20040023854 Adiponectin and uses thereof |
| 02/05/2004 | US20040023843 Treatment of an emotional disorder, which contains the NK-1 receptor antagonist having particular properties of (1) having no serotonin uptake inhibitory effect, (2) being capable of migrating into the hypothalamus, or (3) having an |
| 02/05/2004 | US20040023299 Diagnosis of liver disease |
| 02/05/2004 | US20040022875 Anti peptic ulcer activity of an extract of a plant flower woodfordia fruticosa |
| 02/05/2004 | US20040022872 Antacid and laxative tablets |
| 02/05/2004 | US20040022871 Halogenated composition, method for preparing same and uses thereof |
| 02/05/2004 | US20040022854 Oral administration of proton pump inhibitor |
| 02/05/2004 | US20040022806 Oral preparation containing seaweed for reduction of plaque and calculus |
| 02/05/2004 | US20040022785 Expression of herstatin, an alternative HER-2/neu product, in cells that express either p185HER-2 or the EGF receptor inhibits receptor activity and cell growth |
| 02/05/2004 | US20040022783 Binding agents to CD23 |
| 02/05/2004 | US20040022781 Proteins and nucleic acids encoding same |
| 02/05/2004 | US20040022777 Fragments and antagonists of heat shock protein 60 |
| 02/05/2004 | US20040022758 Hair tonics and method of screening the same |
| 02/05/2004 | CA2495167A1 Structural carotenoid analogs for the inhibition and amelioration of disease |
| 02/05/2004 | CA2494793A1 Novel serine protease |
| 02/05/2004 | CA2494358A1 Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage |
| 02/05/2004 | CA2494102A1 Antagonist of melanin-concentrating hormone receptor comprising benzimidazole derivative as active ingredient |
| 02/05/2004 | CA2494069A1 Pellicle-resistant gelatin capsule |
| 02/05/2004 | CA2494040A1 Multi-step method for the differentiation of insulin positive, glucose |
| 02/05/2004 | CA2493980A1 Gelatin capsule exhibiting reduced cross-linking |
| 02/05/2004 | CA2493913A1 Ppar alpha selective compounds for the treatment of dyslipidemia and other lipid disorders |
| 02/05/2004 | CA2493751A1 Novel arylimidazole derivatives, preparation and therapeutic uses thereof |
| 02/05/2004 | CA2493156A1 Cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 02/05/2004 | CA2492858A1 Use of digoxin immune fab for the regulation of sodium/potassium atpase activity in preeclamptic and eclamptic patients |
| 02/05/2004 | CA2489165A1 Diazabicyclononane and -decane derivatives and their use as opioid receptor ligands |
| 02/04/2004 | EP1386920A1 Benzimidazolone derivatives |
| 02/04/2004 | EP1386908A1 Amine derivative with potassium channel regulatory function, its preparation and use |
| 02/04/2004 | EP1386613A1 Compositions for preparing external carbon dioxide agents |
| 02/04/2004 | EP1386155A2 Therapeutic and diagnostic uses of antibody specificity profiles |
| 02/04/2004 | EP1385977A2 Secreted proteins |
| 02/04/2004 | EP1385966A2 Recombinant fusion proteins and the trimers thereof |
| 02/04/2004 | EP1385934A2 Pufa polyketide synthase systems and uses thereof |
| 02/04/2004 | EP1385883A2 Transmembrane proteins |
| 02/04/2004 | EP1385874A1 Alpha conotoxin peptides with analgesic properties |
| 02/04/2004 | EP1385864A1 Vascular endothelial growth factor 2 |
| 02/04/2004 | EP1385848A2 Phtalazinones derivatives useful as pde4/7 inhibitors |
| 02/04/2004 | EP1385845A1 N-aroyl cyclic amines |
| 02/04/2004 | EP1385843A1 Arylindenopyridines with pde inhibiting activity |
| 02/04/2004 | EP1385842A1 Heterocyclyloxy-, -thioxy- and -aminobenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 02/04/2004 | EP1385841A1 Sulfonamides |
| 02/04/2004 | EP1385840A1 Sulfonamides |
| 02/04/2004 | EP1385839A1 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 02/04/2004 | EP1385836A2 Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 02/04/2004 | EP1385830A1 Sulfonamides |
| 02/04/2004 | EP1385825A1 Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives |
| 02/04/2004 | EP1385822A1 Aminopyrrolidine sulfonamides as serine protease inhibitors |
| 02/04/2004 | EP1385550A2 Therapeutic method for inducing tolerance |
| 02/04/2004 | EP1385535A2 Modified fvii in treatment of ards |
| 02/04/2004 | EP1385532A1 Stimulation of osteogenesis using rank ligand fusion proteins |
| 02/04/2004 | EP1385524A1 Pyrazolopyrimidines as therapeutic agents |
| 02/04/2004 | EP1385519A2 Compounds for treating inflammatory diseases |
| 02/04/2004 | EP1385508A1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 02/04/2004 | EP1385507A1 Sulfonamides |
| 02/04/2004 | EP1385506A2 Acylated piperidine derivates as melanocortin-4 receptor agonists |
| 02/04/2004 | EP1385500A1 Fatty alcohols and fatty acid esters useful for treatment of inflammation |
| 02/04/2004 | EP1385495A2 Sulfonamides |
| 02/04/2004 | EP1385493A1 Substituted cyclohexan-1,4-diamine derivatives with constipating and peripheral analgesic properties |
| 02/04/2004 | EP1385476A2 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions |
| 02/04/2004 | EP1076650B1 Aryl fused azapolycyclic compounds |
| 02/04/2004 | EP1021196B1 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response |
| 02/04/2004 | EP1010424B1 Liver fat accumulation inhibitory composition, food additive for liver fat accumulation inhibition, and method of inhibiting liver fat accumulation |
| 02/04/2004 | EP0684816B1 5-ht2 receptor antagonists for treating venous conditions |
| 02/04/2004 | CN1473161A Pyrazole compounds as protein kinase inhibitors |
| 02/04/2004 | CN1473154A Phthalazinone derivatives |
| 02/04/2004 | CN1473148A Novel crystals of N-hydroxy-2(S)-methyl-5-ethoxymethoxy-4(S)-[N-(4- phenoxyphenylcarbonyl)amino]pentanamide, process for their production and medicines containing crystals as active ingredient |
| 02/04/2004 | CN1473049A Antiacid and laxative tablets |
| 02/04/2004 | CN1473048A 1 alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its therapeutic applications |
| 02/04/2004 | CN1471965A Preparation of cordyceps honey |
| 02/04/2004 | CN1471962A Oral liquid for billiary ascariasis |
| 02/04/2004 | CN1471959A Chronic colonitis ball and preparing method thereof |
| 02/04/2004 | CN1471951A Weibao capsule and preparing method thereof |
| 02/04/2004 | CN1471950A Weibao pillets and their preparing method |
| 02/04/2004 | CN1471942A Preparation of American ginseng honey |
| 02/04/2004 | CN1471940A Reed rhizome sophorae decoction |
| 02/04/2004 | CN1471939A Medicine for treating virus infectious diarrhoea |
| 02/04/2004 | CN1471933A Colonitis recovered capsule |
| 02/04/2004 | CN1471930A Chinese patent drug for treating cholelithiasis |
| 02/04/2004 | CN1471913A Micro-pillet preparation of ranitidine |
| 02/04/2004 | CN1471902A River points line and its production and use for curing coronary, diabetes and enterogastric ulcers |
| 02/04/2004 | CN1137138C Fluridated micellar casein |
| 02/04/2004 | CN1137123C Azolo triazizes and pyrimidines |
| 02/04/2004 | CN1137120C 5,11-Dihydrodibenz[b,e][1,4] oxazepine derivatives and medical composition containg the same |
| 02/04/2004 | CN1137100C Tricyclic compounds capable of inhibiting tyrosine kinases of epidermal growth factor receptor family |
| 02/04/2004 | CN1137097C Aminoalkyl-3,4-dihydroquindine derivates as No-synthase inhibitors |
| 02/04/2004 | CN1137083C New benzocyclobutane compounds, process for their preparation and pharmaceutical compositions containing them |
| 02/04/2004 | CN1136911C Medicine for treating stomach disease |
| 02/04/2004 | CN1136907C Making process of enzume degrading oral liquid |
| 02/04/2004 | CN1136905C Chewing tablet capable of eliminating garlic smell in oral cavity |
| 02/04/2004 | CN1136902C Wetness-evil eliminating and dyspepsia relieving medine tablet and prepn method thereof |
| 02/04/2004 | CN1136896C Live-nourishing 'yanggan' pill |
| 02/04/2004 | CN1136891C Freeze dried compound queen bee powder |
| 02/04/2004 | CN1136886C Externally dressing medicine for treating cholecystitis |
| 02/04/2004 | CN1136872C Anorexia treating oral liquid |
| 02/04/2004 | CN1136871C Traditional Chinese medicine for treating burn and scald and preparation process thereof |
| 02/04/2004 | CN1136869C Recovery capsule for hepatitis and its preparing process |
| 02/04/2004 | CN1136849C Gastric floating slow-releasing tinidazole capsule and its preparing method |